866-997-4948(US-Canada Toll Free)

Global Remicade Biosimilar Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 113 Pages

This report studies the global market size of Remicade Biosimilar in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Remicade Biosimilar in these regions.
This research report categorizes the global Remicade Biosimilar market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Remicade Biosimilar market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Remicade Biosimilar market based on company, product type, application and key regions.

The various contributors involved in the value chain of Remicade Biosimilar include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Remicade Biosimilar include
Teva Pharmaceutical Industries
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)

Market Size Split by Type
100mg/10ml
500mg/50ml
Market Size Split by Application
Blood Disorders
Oncology Diseases

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Remicade Biosimilar market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Remicade Biosimilar market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Remicade Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Remicade Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Remicade Biosimilar submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Remicade Biosimilar are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Remicade Biosimilar market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Remicade Biosimilar Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Remicade Biosimilar Market Size Growth Rate by Type
1.4.2 100mg/10ml
1.4.3 500mg/50ml
1.5 Market by Application
1.5.1 Global Remicade Biosimilar Market Size Growth Rate by Application
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Remicade Biosimilar Market Size
2.1.1 Global Remicade Biosimilar Revenue 2016-2025
2.1.2 Global Remicade Biosimilar Sales 2016-2025
2.2 Remicade Biosimilar Growth Rate by Regions
2.2.1 Global Remicade Biosimilar Sales by Regions
2.2.2 Global Remicade Biosimilar Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Remicade Biosimilar Sales by Manufacturers
3.1.1 Remicade Biosimilar Sales by Manufacturers
3.1.2 Remicade Biosimilar Sales Market Share by Manufacturers
3.1.3 Global Remicade Biosimilar Market Concentration Ratio (CR5 and HHI)
3.2 Remicade Biosimilar Revenue by Manufacturers
3.2.1 Remicade Biosimilar Revenue by Manufacturers (2016-2018)
3.2.2 Remicade Biosimilar Revenue Share by Manufacturers (2016-2018)
3.3 Remicade Biosimilar Price by Manufacturers
3.4 Remicade Biosimilar Manufacturing Base Distribution, Product Types
3.4.1 Remicade Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Remicade Biosimilar Product Category
3.4.3 Date of International Manufacturers Enter into Remicade Biosimilar Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Remicade Biosimilar Sales by Type
4.2 Global Remicade Biosimilar Revenue by Type
4.3 Remicade Biosimilar Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Remicade Biosimilar Breakdown Data by Application

6 North America
6.1 North America Remicade Biosimilar by Countries
6.1.1 North America Remicade Biosimilar Sales by Countries
6.1.2 North America Remicade Biosimilar Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Remicade Biosimilar by Type
6.3 North America Remicade Biosimilar by Application
6.4 North America Remicade Biosimilar by Company

7 Europe
7.1 Europe Remicade Biosimilar by Countries
7.1.1 Europe Remicade Biosimilar Sales by Countries
7.1.2 Europe Remicade Biosimilar Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Remicade Biosimilar by Type
7.3 Europe Remicade Biosimilar by Application
7.4 Europe Remicade Biosimilar by Company

8 Asia Pacific
8.1 Asia Pacific Remicade Biosimilar by Countries
8.1.1 Asia Pacific Remicade Biosimilar Sales by Countries
8.1.2 Asia Pacific Remicade Biosimilar Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Remicade Biosimilar by Type
8.3 Asia Pacific Remicade Biosimilar by Application
8.4 Asia Pacific Remicade Biosimilar by Company

9 Central & South America
9.1 Central & South America Remicade Biosimilar by Countries
9.1.1 Central & South America Remicade Biosimilar Sales by Countries
9.1.2 Central & South America Remicade Biosimilar Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Remicade Biosimilar by Type
9.3 Central & South America Remicade Biosimilar by Application
9.4 Central & South America Remicade Biosimilar by Company

10 Middle East and Africa
10.1 Middle East and Africa Remicade Biosimilar by Countries
10.1.1 Middle East and Africa Remicade Biosimilar Sales by Countries
10.1.2 Middle East and Africa Remicade Biosimilar Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Remicade Biosimilar by Type
10.3 Middle East and Africa Remicade Biosimilar by Application
10.4 Middle East and Africa Remicade Biosimilar by Company

11 Company Profiles
11.1 Teva Pharmaceutical Industries
11.1.1 Teva Pharmaceutical Industries Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.1.4 Remicade Biosimilar Product Description
11.1.5 Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.2.4 Remicade Biosimilar Product Description
11.2.5 Recent Development
11.3 LG Life Sciences
11.3.1 LG Life Sciences Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.3.4 Remicade Biosimilar Product Description
11.3.5 Recent Development
11.4 Novartis (Sandoz)
11.4.1 Novartis (Sandoz) Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.4.4 Remicade Biosimilar Product Description
11.4.5 Recent Development
11.5 Celltrion
11.5.1 Celltrion Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.5.4 Remicade Biosimilar Product Description
11.5.5 Recent Development
11.6 Biocon
11.6.1 Biocon Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.6.4 Remicade Biosimilar Product Description
11.6.5 Recent Development
11.7 Hospira
11.7.1 Hospira Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.7.4 Remicade Biosimilar Product Description
11.7.5 Recent Development
11.8 Merck Serono (Merck Group)
11.8.1 Merck Serono (Merck Group) Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.8.4 Remicade Biosimilar Product Description
11.8.5 Recent Development
11.9 Biogen idec Inc.
11.9.1 Biogen idec Inc. Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.9.4 Remicade Biosimilar Product Description
11.9.5 Recent Development
11.10 Genentech (Roche Group)
11.10.1 Genentech (Roche Group) Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Remicade Biosimilar
11.10.4 Remicade Biosimilar Product Description
11.10.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Remicade Biosimilar Raw Material
13.1.2 Remicade Biosimilar Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Remicade Biosimilar
Figure Global Remicade Biosimilar Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Remicade Biosimilar Production Market Share by Types (Product Category) in 2017
Figure 100mg/10ml Product Picture
Table Major Manufacturers of 100mg/10ml
Figure 500mg/50ml Product Picture
Table Major Manufacturers of 500mg/50ml
Table Global Remicade Biosimilar Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Blood Disorders
Figure Oncology Diseases
Figure Remicade Biosimilar Report Years Considered
Figure Global Remicade Biosimilar Market Size 2016-2025 (Million US$)
Figure Global Remicade Biosimilar Sales 2016-2025 (K Units)
Table Global Remicade Biosimilar Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Remicade Biosimilar Sales by Regions 2016-2025 (K Units)
Table Global Remicade Biosimilar Sales Market Share by Regions 2016-2025
Figure Global Remicade Biosimilar Sales Market Share by Regions 2016-2025
Figure 2017 Global Remicade Biosimilar Sales Market Share by Regions
Table Global Remicade Biosimilar Revenue by Regions 2016-2025 (Million US$)
Table Global Remicade Biosimilar Revenue Market Share by Regions 2016-2025
Figure Global Remicade Biosimilar Revenue Market Share by Regions 2016-2025
Figure 2017 Global Remicade Biosimilar Revenue Market Share by Regions
Table Global Remicade Biosimilar Sales by Manufacturers (2016-2018) (K Units)
Table Global Remicade Biosimilar Sales Share by Manufacturers (2016-2018)
Figure Global Remicade Biosimilar Sales Share by Manufacturers in 2017
Table Remicade Biosimilar Revenue by Manufacturers (2016-2018) (Million US$)
Table Remicade Biosimilar Revenue Share by Manufacturers (2016-2018)
Figure Remicade Biosimilar Value Share by Manufacturers in 2017
Table Global Remicade Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Remicade Biosimilar Price (2016-2018) (USD/Unit)
Table Remicade Biosimilar Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Remicade Biosimilar Product Category
Table Date of International Manufacturers Enter into Remicade Biosimilar Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Remicade Biosimilar Sales by Type (2016-2025) (K Units)
Table Global Remicade Biosimilar Sales Share by Type (2016-2025)
Figure Global Remicade Biosimilar Sales Market Share by Type (2016-2025)
Figure Global Remicade Biosimilar Sales Market Share by Type in 2017
Table Global Remicade Biosimilar Revenue by Type (2016-2025) (Million US$)
Table Global Remicade Biosimilar Revenue Share by Type (2016-2025)
Figure Global Remicade Biosimilar Revenue Market Share by Type (2016-2025)
Figure Global Remicade Biosimilar Revenue Market Share by Type in 2017
Table Remicade Biosimilar Price by Type 2013-2018 (USD/Unit)
Table Global Remicade Biosimilar Sales by Application (2016-2025) (K Units)
Table Global Remicade Biosimilar Sales Share by Application (2016-2025)
Figure Global Sales Remicade Biosimilar Market Share by Application (2016-2025)
Figure Global Sales Remicade Biosimilar Market Share by Application (2016-2025)
Figure North America Remicade Biosimilar Sales Growth Rate 2016-2025 (K Units)
Figure North America Remicade Biosimilar Revenue Growth Rate 2016-2025 (Million US$)
Table North America Remicade Biosimilar Sales by Countries (2016-2025) (K Units)
Table North America Remicade Biosimilar Sales Market Share by Countries (2016-2025)
Figure 2017 North America Remicade Biosimilar Sales Market Share by Countries
Table North America Remicade Biosimilar Revenue by Countries (2016-2025) (Million US$)
Table North America Remicade Biosimilar Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Remicade Biosimilar Revenue Market Share by Countries
Figure United States Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure United States Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Canada Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Table North America Remicade Biosimilar Sales by Type (2016-2025) (K Units)
Table North America Remicade Biosimilar Sales Market Share by Type (2016-2025)
Figure 2017 North America Remicade Biosimilar Market Share by Type
Table North America Remicade Biosimilar Sales by Application (2016-2025) (K Units)
Table North America Remicade Biosimilar Sales Market Share by Application (2016-2025)
Figure 2017 North America Remicade Biosimilar Market Share by Application
Table North America Remicade Biosimilar Sales by Company (2016-2018) (K Units)
Table North America Remicade Biosimilar Sales Market Share by Company (2016-2018)
Figure North America Remicade Biosimilar Sales Market Share by Company in 2017
Figure Europe Remicade Biosimilar Sales Growth Rate 2016-2025 (K Units)
Figure Europe Remicade Biosimilar Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Remicade Biosimilar Sales by Countries (2016-2025) (K Units)
Table Europe Remicade Biosimilar Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Remicade Biosimilar Sales Market Share by Countries
Table Europe Remicade Biosimilar Revenue by Countries (2016-2025) (Million US$)
Table Europe Remicade Biosimilar Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Remicade Biosimilar Revenue Market Share by Countries
Figure Germany Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Germany Remicade Biosimilar Revenue Growth Rate (2016-2025) (K Units)
Figure France Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure France Remicade Biosimilar Revenue Growth Rate (2016-2025) (K Units)
Figure UK Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure UK Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Italy Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Russia Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Remicade Biosimilar Sales by Type (2016-2025) (K Units)
Table Europe Remicade Biosimilar Sales Market Share by Type (2016-2025)
Figure 2017 Europe Remicade Biosimilar Market Share by Type
Table Europe Remicade Biosimilar Sales by Application (2016-2025) (K Units)
Table Europe Remicade Biosimilar Sales Market Share by Application (2016-2025)
Figure 2017 Europe Remicade Biosimilar Market Share by Application
Table Europe Remicade Biosimilar Sales by Company (2016-2018) (K Units)
Table Europe Remicade Biosimilar Sales Market Share by Company (2016-2018)
Figure Europe Remicade Biosimilar Sales Market Share by Company in 2017
Figure Asia Pacific Remicade Biosimilar Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Remicade Biosimilar Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Remicade Biosimilar Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Remicade Biosimilar Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Remicade Biosimilar Sales Market Share by Countries
Table Asia Pacific Remicade Biosimilar Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Remicade Biosimilar Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Remicade Biosimilar Revenue Market Share by Countries
Figure China Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure China Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Japan Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Korea Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure India Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure India Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Australia Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Remicade Biosimilar Sales by Type (2016-2025) (K Units)
Table Asia Pacific Remicade Biosimilar Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Remicade Biosimilar Market Share by Type
Table Asia Pacific Remicade Biosimilar Sales by Application (2016-2025) (K Units)
Table Asia Pacific Remicade Biosimilar Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Remicade Biosimilar Market Share by Application
Table Asia Pacific Remicade Biosimilar Sales by Company (2016-2018) (K Units)
Table Asia Pacific Remicade Biosimilar Sales Market Share by Company (2016-2018)
Figure Asia Pacific Remicade Biosimilar Sales Market Share by Company in 2017
Figure Central & South America Remicade Biosimilar Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Remicade Biosimilar Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Remicade Biosimilar Sales by Countries (2016-2025) (K Units)
Table Central & South America Remicade Biosimilar Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Remicade Biosimilar Sales Market Share by Countries
Table Central & South America Remicade Biosimilar Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Remicade Biosimilar Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Remicade Biosimilar Revenue Market Share by Countries
Figure Brazil Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Remicade Biosimilar Sales by Type (2016-2025) (K Units)
Table Central & South America Remicade Biosimilar Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Remicade Biosimilar Market Share by Type
Table Central & South America Remicade Biosimilar Sales by Application (2016-2025) (K Units)
Table Central & South America Remicade Biosimilar Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Remicade Biosimilar Market Share by Application
Table Central & South America Remicade Biosimilar Sales by Company (2016-2018) (K Units)
Table Central & South America Remicade Biosimilar Sales Market Share by Company (2016-2018)
Figure Central & South America Remicade Biosimilar Sales Market Share by Company in 2017
Figure Middle East and Africa Remicade Biosimilar Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Remicade Biosimilar Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Remicade Biosimilar Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Remicade Biosimilar Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Remicade Biosimilar Sales Market Share by Countries
Table Middle East and Africa Remicade Biosimilar Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Remicade Biosimilar Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Remicade Biosimilar Revenue Market Share by Countries
Figure GCC Countries Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Remicade Biosimilar Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Remicade Biosimilar Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Remicade Biosimilar Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Remicade Biosimilar Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Remicade Biosimilar Market Share by Type
Table Middle East and Africa Remicade Biosimilar Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Remicade Biosimilar Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Remicade Biosimilar Market Share by Application
Table Middle East and Africa Remicade Biosimilar Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Remicade Biosimilar Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Remicade Biosimilar Sales Market Share by Company in 2017
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Pharmaceutical Industries Recent Development
Table Synthon Pharmaceuticals Company Details
Table Synthon Pharmaceuticals Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Synthon Pharmaceuticals Recent Development
Table LG Life Sciences Company Details
Table LG Life Sciences Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table LG Life Sciences Recent Development
Table Novartis (Sandoz) Company Details
Table Novartis (Sandoz) Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis (Sandoz) Recent Development
Table Celltrion Company Details
Table Celltrion Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Celltrion Recent Development
Table Biocon Company Details
Table Biocon Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Biocon Recent Development
Table Hospira Company Details
Table Hospira Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Hospira Recent Development
Table Merck Serono (Merck Group) Company Details
Table Merck Serono (Merck Group) Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Serono (Merck Group) Recent Development
Table Biogen idec Inc. Company Details
Table Biogen idec Inc. Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Biogen idec Inc. Recent Development
Table Genentech (Roche Group) Company Details
Table Genentech (Roche Group) Remicade Biosimilar Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Genentech (Roche Group) Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Remicade Biosimilar Value Chain
Table Typical Suppliers of Key Remicade Biosimilar Raw Material
Table Remicade Biosimilar Customers List
Table Remicade Biosimilar Sales Channels
Table Remicade Biosimilar Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *